Harvard Bioscience to showcase latest solutions

Harvard Bioscience announced that it will be showcasing its latest product innovations at the Society of Toxicology, SOT, conference from March 11-13, 2024, in Salt Lake City. Complementing an already extensive product line, the new innovations provide exciting new opportunities for advancing preclinical and organoid-focused therapy development. Jim Green, Harvard Bioscience Chairman and CEO, said, “We are pleased to offer our CRO, pharma, and biotech customers innovative products designed to reduce cycle times, improve throughput, and reduce time to market. Looking to the future, I’m especially excited by the potential of our Ponemah platform to advance the use of emerging artificial intelligence and machine learning technologies to streamline data analysis and reporting in applications such as toxicology and organoid testing.”